Glacier: An open-label, randomized, multicenter study to assess safety and tolerability of glatiramer acetate 40 mg/1mL 3-times weekly versus 20 mg/1mL daily in patients with relapsing-remitting multiple sclerosis

Authors
Category Primary study
JournalNeurology
Year 2014
This article has no abstract
Epistemonikos ID: ee7fb4361b7e3278c54a9b5a8b25e9048c38765a
First added on: Feb 06, 2025